Gift cards—once seen mostly as an afterthought gift—have become one of the holiday season’s more-popular presents. But many people don’t get maximum value from them. Consider Bankrate research that ...

Dec 1 (Reuters) - The World Health Organization on Monday issued its first guideline on the use of GLP-1 therapies for obesity, conditionally recommending them as part of long-term treatment for the ...

You’re reading The Checkup With Dr. Wen, a newsletter on how to navigate medical and public health challenges. Click here to get the full newsletter in your inbox, including answers to reader ...

Rep. James Comer, R-Ky., insisted Tuesday that "every pardon" signed by former President Joe Biden should be "null and void," telling Fox News' Laura Ingraham that the process was riddled with ...

House Republicans have asked the Justice Department to launch an investigation into the Biden administration’s autopen use. In a 100-page report released Tuesday, the House Oversight Committee ...

House Republicans are calling on the Justice Department to launch an investigation into the Biden administration’s use of an autopen, an effort they hope will unwind various actions taken by former ...

What if you could build an intelligent agent that not only understands your workflow but also transforms it, automating complex tasks, analyzing intricate data, and delivering actionable insights with ...

What if your AI agents could seamlessly handle complex workflows, pulling data from Airtable, summarizing YouTube transcripts, or automating your Google Calendar, all without breaking a sweat? That’s ...

New survey data finds that nearly 1 in 5 high schoolers say they or someone they know has had a romantic relationship with artificial intelligence. And 42% of students surveyed say they or someone ...

Microsoft’s declarative REST and GraphQL API design tool supports MySQL and Postgres as well as Azure databases and works anywhere you can run a Docker container. Microsoft Azure is now so big it’s ...

The proportion of Medicare Part D beneficiaries subject to prior authorization for GLP-1 drugs jumped from just a fraction through 2023 to nearly all by 2025. Out-of-pocket costs likewise were steady ...